cigna glp-1 coverage news today doubles down on support programs with 2 new launches Health insurer Cigna will stop

Such interest could result in GLP-1 penetration reaching nearly 20% of the US adult population within two years, and the pill format could expand the active GLP-1 user population by as much as 50% by 2027, according to Big Chalk

After 16 to 20 weeks of treatment with Xolair, 68% of patients could handle at least 600 mg of peanut protein without moderate to severe allergic symptoms

December 2, 2025: Modest Growth for Ozempic Gastroparesis MDL There are now 2,947 active lawsuits in the MDL focused on claims involving GLP-1 drugs and intestinal conditions like gastroparesis

No pain, no urinary issues, no warning

Orlynvahs approval was supported by two Phase III trials

Not patches